Table 1 Demographic information of participants at baseline (N = 283)
From: Evaluation of PDQ-8 and its relationship with PDQ-39 in China: a three-year longitudinal study
Median | Quartile/Percentage | Floor/Ceiling % | |
|---|---|---|---|
Gender (male) | 166 | 58.7% | |
Age (year) | 57 | 45–64 | |
Age of onset (year) | 51 | 41–60 | |
Duration of disease (month) | 36 | 18–67 | |
Education (year) | |||
< 7 | 29 | 10.2% | |
7–12 | 145 | 51.1% | |
> 12 | 109 | 38.5% | |
H&Y stage | |||
1 | 71 | 25.1% | |
2 | 130 | 45.9% | |
3 | 73 | 25.7% | |
4 | 7 | 2.5% | |
5 | 2 | 0.7% | |
UPDRS-III | 30 | 20–38 | |
LEDD (mg) | 300 | 75–451 | |
BDI | 11 | 6.0–18.0 | |
MMSE | 28 | 27–29 | |
PDQ-8-SI | 18.8 | 9.4–31.3 | 6.0%/0 |
PDQ-39-SI | 17.3 | 9.0–27.6 | 0.4%/0 |
Mobility | 15 | 5.0–30.0 | 14.5%/0 |
Activity of daily living | 12.5 | 0.0–28.2 | 25.8%/0 |
Emotional well-being | 16.7 | 8.3–33.3 | 15.5%/0.4% |
Stigma | 18.8 | 0.0–37.5 | 25.1%/2.5% |
Social support | 0 | 0.0–8.3 | 63.6%/0.4% |
Cognitions | 18.8 | 12.5–36.0 | 11.7%/0.4% |
Communication | 8.3 | 0.0–25.0 | 45.9%/0.4% |
Bodily discomfort | 25 | 8.3–41.7 | 18.7%/0.7% |